Vehicle proprietary ophthalmic solution

DRUG2 trials

Sponsors

LENZ Therapeutics, Inc

Conditions

Eye DiseasesPresbyopiaRefractive Errors

Phase 2

Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia

CompletedNCT05294328

LENZ Therapeutics, IncEye Diseases, Presbyopia, Refractive Errors

Start: 2022-05-05End: 2022-09-10Updated: 2024-09-05

Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of Presbyopia

CompletedNCT05431543

LENZ Therapeutics, IncEye Diseases, Presbyopia, Refractive Errors

Start: 2022-08-06End: 2022-12-14Updated: 2024-09-05